DPYSL2 and viral encephalitis: To further evaluate the potential contribution of CRMP2 to neurogenic alterations in the pathogenesis of HIV in the brain, we examined expression levels and patterns of immunoreactivity of CRMP2 in the hippocampus of HIV patients with and without encephalitis (patient demographics and clinic-pathological characteristics presented in Table 2).